StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.0
  1. Startseite
  2. /Verbindung

Hippursure

Hippuric Acid

HCID 464
Neue NotizNeue ReaktionAnfrage stellen
Druckvorschau
GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
495-69-2
Standard-SMILES
O=C(O)CNC(=O)c1ccccc1
InChIKey
QIAFMBKCNZACKA-UHFFFAOYSA-N
Summenformel
C9H9NO3
Durchschnittliche Molmasse
179,17 g/mol
Monoisotopische Masse
179,05824315

Überblick

N-benzoylglycine is an N-acylglycine in which the acyl group is specified as benzoyl. It has a role as a uremic toxin and a human blood serum metabolite. It is a conjugate acid of a N-benzoylglycinate.

Namen und Bezeichner

Bevorzugter Name
Hippuric Acid
IUPAC
2-benzamidoacetic acid
Lokaler Name
Hippursure
Englischer Name
Hippuric acid
Summenformel
C9H9NO3
Molmasse
179.17

Namen und Synonyme

Hippuric acid495-69-22-Benzamidoacetic acidN-BenzoylglycineBenzoylglycineGlycine, N-benzoyl-hippurateBenzamidoacetic acidBenzoylaminoacetic acidHippursaeurePhenylcarbonylaminoacetic acidBenzamidoessigsaeure
Weitere Namen anzeigen
hippuricHIPURIC ACIDBZ-GLY-OHAKOS B029712CPD-425
2-(Phenylformamido)Acetic AcidBenzoylaminoessigsaeureAcido ippuricoDTXSID9046073TE0865N2ETHIPPURICUM ACIDUMNSC-9982DTXCID7026073

Datenbank-Bezeichner

CAS
495-69-2
PubChem CID
464
DTXSID
DTXSID9046073
ChEMBL
CHEMBL461
ChEBI
CHEBI:18089
UNII
TE0865N2ET
EC Number
207-806-3
Nikkaji
J1.562H

Eigenschaften

Berechnete Struktureigenschaften

XLogP
0,3
Polarare Oberfläche (TPSA)
66,4 Ų
H-Brücken-Donoren
2
H-Brücken-Akzeptoren
3
Frei drehbare Bindungen
3
Schwere Atome
13
Formalladung
0
Komplexität
197

Experimentelle und physikochemische Eigenschaften

Chemical ClassesNitrogen Compounds -> Amino Carboxylic Acids
DrugsPharmaceuticals -> Metabolite of Fluoxetine, Lisdexamfetamine
CosmeticsHair conditioning
SpringerMaterials PropertiesCrystal structure
LogP · 2 Einträge

0.31

0.31

Solubility3.75 mg/mL
Melting Point187 - 191 °C
Vapor Pressure0.00000076 [mmHg]
Physical Description · 2 Einträge

Solid; [Merck Index] White crystalline powder; [Alfa Aesar MSDS]

Solid

Collision Cross Section · 4 Einträge

139.72 Ų [M-H]- [CCS Type: DT; Method: single field calibrated with Agilent tune mix (Agilent)]

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 5 Einträge

This chemical does not meet GHS hazard criteria for 5.2% (3 of 58) of reports.

Danger

H302 (93.1%): Harmful if swallowed [Warning Acute toxicity, oral]

P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P354+P338, P317, P319, P321, P330, P332+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 58 reports by companies from 8 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Gefahrenhinweise

Regulatory Information · 3 Einträge

Chemical: Glycine, N-benzoyl-

REACH registered substance: Hippuric acid (EC: 207-806-3)

Glycine, N-benzoyl-: Does not have an individual approval but may be used under an appropriate group standard

Other Safety InformationEvaluation - Chemicals that are unlikely to require further regulation to manage risks to environment
Hazards Summary · 1 Eintrag

The glycine conjugate of benzoic acid and a human metabolite of toluene; Has been measured in urine as an indicator of occupational exposure to toluene (in the absence of xylene and styrene exposure); [NIOSH Manual of Analytical Methods] May cause irritation; [Alfa Aesar MSDS]

Hazard Classes and CategoriesAcute Tox. 4 (93.1%)

Toxikologische Informationen

TreatmentKidney dialysis is usually needed to relieve the symptoms of uremic syndrome until normal kidney function can be restored.

Chemie und Industrie

Pharmakologische Informationen

Metabolism/MetabolitesUremic toxins tend to accumulate in the blood either through dietary excess or through poor filtration by the kidneys. Most uremic toxins are metabolic waste products and are normally excreted in the urine or feces.
Tissue LocationsKidney
Cellular LocationsCytoplasm

Verwendung und Herstellung

Uses · 2 Einträge

Found in the urine of herbivorous animals and humans; [Merck Index]

Naturally produced by the body (endogenous).

Use ClassificationCosmetics -> Hair conditioning
General Manufacturing InformationGlycine, N-benzoyl-: ACTIVE
Anwendungen · 1 Eintrag

VerwendenN-Benzoylglycine also known as Hippuric Acid is the glycine conjugate of benzoic acid commonly found in ruminant urine. It is synthesized in the liver and its production is greatly increased following consuption of benzoic acid. In itself it does not have a direct biological function, however p-hydroxy-hippurica acid can be used as an inhibitor of Ca2+ ATPase.

Darstellung · 1 Eintrag

synthetischePreparation of Hippuric acid from Glycine. Principle: The hydroxy and amino functions can be easily benzoylated using Benzoyl chloride in aqueous alkaline conditions. This reaction is known as Schotten-Baumann reaction. Reaction: Procedure: Dissolve 0.5 g of glycine in 5 ml of 10% NaOH solution in a 25 ml conical flask. Add 0.9 ml of benzoyl chloride in five portions to the solution. Stopper the flask and shake vigorously after each addition until all the benzoyl chloride is reacted. Transfer the solution to a beaker and add few grams of ice and add conc. HCl slowly with stirring until the solution is acidic to litmus paper. Filter the crystalline precipitate of the product on a Buchner funnel, wash with cold water and drain well. Place the solid in a conical flask with 10 ml CCl4 and boil gently for 10 min. Allow the mixture to cool slightly, filter under gentle suction and wash with 10-20 ml CCl4. Record the practical yield and re-crystallize it. Re-crystallization: Dissolve the crude product from boiling water (5 ml), with addition of decolorizing charcoal if necessary, filter the hot solution and cool the filtrate. The crystals of the product separate out. Filter, dry and record the melting point and TLC [using Butanal : acetic acid: water (4 : 1 : 1) as solvent or CHCl3:methanol (9 : 1) or toluene].

Zugehörige Reaktionen

92
Reaktionsaufzeichnung erstellen
Reaktionsgleichung von HRID 4494
HRID 4494als Eduktuspto-grants-1988_02
Reaktionsgleichung von HRID 117216
HRID 117216als EduktTraining data from https://doi.org/10.1039/C8SC04228D (2/10)
Reaktionsgleichung von HRID 133552
HRID 133552als Eduktuspto-grants-2008_06
Reaktionsgleichung von HRID 133587
HRID 133587als Eduktuspto-grants-2008_06
Reaktionsgleichung von HRID 140002
HRID 140002als EduktTraining data from https://doi.org/10.1039/C8SC04228D (9/10)
Reaktionsgleichung von HRID 190629
HRID 190629als EduktTraining data from https://doi.org/10.1039/C8SC04228D (6/10)
Reaktionsgleichung von HRID 215258
HRID 215258als EduktTraining data from https://doi.org/10.1039/C8SC04228D (6/10)
Reaktionsgleichung von HRID 215939
HRID 215939als Eduktuspto-grants-2012_06
Seite 1 von 12

Notizen zur Verbindung

Wird geladen…

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
Weitere Aktionen
Neue NotizNeue ReaktionAnfrage stellen

142 Ų [M-H]- [CCS Type: DT; Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]

154.06 Ų [M+Na]+ [CCS Type: DT; Method: stepped-field]

145.9 Ų [M+H]+

Physikochemische Eigenschaften

Schmelzpunkt
187 · 187-191 °C (lit.)
Siedepunkt
311.69 °C · 311.69°C (rough estimate)
Dichte
1 · 1,371 g/cm3
Brechungsindex
1.56 · 1.5600 (estimate)
storage temp.
30 °C · Store below +30°C.
Löslichkeit
3.26 g/l · 3.26g/l
Aggregatzustand
Crystalline Powder
pka
3.62 · 3.62(at 25℃)
Farbe
White to almost white
PH
2.5 · 2.5-3.5 (10g/l, H2O, 20℃)(slurry)
Wasserlöslichkeit
Soluble in water.
Merck
14 · 14,4716
BRN
1073987 · 1073987
Stabilität
Stable. Incompatible with oxidizing agents.
Major Application
clinical testing
Kosmetik-Inhaltsstoffe Funktionen
HAIR CONDITIONING
InChI
1S/C9H9NO3/c11-8(12)6-10-9(13)7-4-2-1-3-5-7/h1-5H,6H2,(H,10,13)(H,11,12)
InChIKey
QIAFMBKCNZACKA-UHFFFAOYSA-N
SMILES
OC(=O)CNC(=O)c1ccccc1
LogP
0.771 · 0.771
CAS Datenbank
495 · 495-69-2(CAS DataBase Reference)
EPA chemische Informationen
Glycine, N-benzoyl- (495-69-2)
Health EffectsChronic exposure to uremic toxins can lead to a number of conditions including renal damage, chronic kidney disease and cardiovascular disease.
Exposure RoutesEndogenous, Ingestion, Dermal (contact)
Toxicity Summary · 1 Eintrag

Uremic toxins such as hippuric acid are actively transported into the kidneys via organic ion transporters (especially OAT3). Increased levels of uremic toxins can stimulate the production of reactive oxygen species. This seems to be mediated by the direct binding or inhibition by uremic toxins of the enzyme NADPH oxidase (especially NOX4 which is abundant in the kidneys and heart) (A7868). Reactive oxygen species can induce several different DNA methyltransferases (DNMTs) which are involved in the silencing of a protein known as KLOTHO. KLOTHO has been identified as having important roles in anti-aging, mineral metabolism, and vitamin D metabolism. A number of studies have indicated that KLOTHO mRNA and protein levels are reduced during acute or chronic kidney diseases in response to high local levels of reactive oxygen species (A7869).

Signs and Symptoms · 1 Eintrag

As a uremic toxin, this compound can cause uremic syndrome. Uremic syndrome may affect any part of the body and can cause nausea, vomiting, loss of appetite, and weight loss. It can also cause changes in mental status, such as confusion, reduced awareness, agitation, psychosis, seizures, and coma. Abnormal bleeding, such as bleeding spontaneously or profusely from a very minor injury can also occur. Heart problems, such as an irregular heartbeat, inflammation in the sac that surrounds the heart (pericarditis), and increased pressure on the heart can be seen in patients with uremic syndrome. Shortness of breath from fluid buildup in the space between the lungs and the chest wall (pleural effusion) can also be present.

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).

Sicherheitsdaten

F
3-10
wgk
3
tsca
TSCA listed
hs_code
2924299090
RTECS-Nr.
MR8150000
risk_code
22-37/38-41-36/37/38
hazard_code
Xn,Xi
safety_code
26-39-36/37-22
hazard_class
IRRITANT
Speicherklasse
11 - Combustible Solids

Vor- und nachgelagerte Produkte

Vorgelagerte Rohstoffe

Formyl chlorideNatriumglycinatGlycinBenzoylchlorid2-Mercaptopropionsäure

Nachgelagerte Produkte

2-Benzamido-3-(4-(N,N-bis-(2-chloroethyl)amino)phenyl)propionic acidDL-allo-Isoleucin3,4-Dimethoxyphenylessigsure3,4-DihydroxyphenylessigsureDL-3-(4-Fluorphenyl)alaninBenzoesureGlycinhydrochlorid(Z)-N-(1-chloro-1-(2-methoxyphenyl)-3-oxo-3-(piperidin-1-yl)prop-1-en-2-yl)benzamideBUTTPARK 61\40-87

Ergänzende Hinweise

DefinitionChEBI: An N-acylglycine in which the acyl group is specified as benzoyl.